Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Article | IMSEAR | ID: sea-210789

ABSTRACT

A feeding trial was conducted to discern the effect of dietary incorporation of aniseed and ginger rhizome powder on growth performance and nutrient utilization in commercial broiler chickens. A total of 120, day-old broiler chicks were divided randomly into 4 treatment groups with 3 replicates each i.e. 10 broiler chicks per replicate. The feeding trial lasted for 42 days viz., A metabolism trial was conducted during the 6th week of feeding trial to know the nutrient utilization. During the starter phase, maximum weight gain was recorded in broiler chicks of treatment group T3 (827.70 g) fed diet incorporated with 1.0% ginger rhizome powder followed by treatment groups T1, T2 and T4, however, there was no significant difference in body weight gain amongst the different treatment groups. During finisher phase, the average body weight gain was 1313.50, 1365.32, 1308.20 and 1291.36 g in broiler chicks of treatment groups T1, T2, T3 and T4, respectively and did not differ significantly among different groups. During entire feeding trial period (0-42 days), incorporation of aniseed and ginger rhizome powder in the basal diets non-significantly improved growth performance in terms of body weight gain, feed conversion ratio and performance index. The average cumulative body weight gain was 2120.57, 2152.75, 2135.90 and 2064.43 g in broiler chicks of treatment groups T1, T2, T3 and T4, respectively and did not differ significantly among different groups. There was no significant difference in nutrient utilization among different treatment groups of broiler chickens

2.
Article in English | IMSEAR | ID: sea-177651

ABSTRACT

Background: We studied the sedative and analgesic effect of intravenous dexmedetomidine in patients posted for meshplasty for the repair of inguinal hernia under subarachnoid block with 0.5% hyperbaric bupivacaine. Methods: Fifty patients of the American Society of Anaesthesiologists (ASA) physical status I or II of either sex (20 – 50 years) presenting for meshplasty for inguinal hernia were included in the prospective double-blind randomized study. All patients received 2.5 ml of 0.5% hyperbaric bupivacaine intrathecally. Patients were randomly allocated on the basis of a sealed envelope technique to receive one of the following after subarachnoid block: Group D (n=25) - Loading dose of 1 μg kg-1 dexmedetomidine over 10 minutes started 20 minutes after spinal block + maintenance dose of 0.4 μg kg-1 hr-1 dexmedetomidine till the end of surgery; Group P (n=25) - same calculated volume of normal saline as a loading dose over 10 minutes + maintenance till end of surgery. Data regarding the VAS score, duration of analgesia were recorded. Results: Patients in group D had a significantly higher sedation score than those in group P (p< 0.001). Dexmedetomidine significantly reduced the requirement of diclofenac injection for pain relief in 24 hours postoperative period (p< 0.001). Conclusion: Intravenous dexmedetomidine resulted in significant prolongation of time to VAS ≥ 4, reduced postoperative analgesic requirement and produced good sedation levels without significant haemodynamic compromise.

3.
Article in English | IMSEAR | ID: sea-22877

ABSTRACT

BACKGROUND & OBJECTIVES: Methicillin-resistant Staphylococcus aureus (MRSA), a major nosocomial pathogen world-wide, is often difficult to detect due to the heterogeneous nature of expression of oxacillin resistance. In the present study, various conventional methods were compared with polymerase chain reaction on 106 clinical isolates of Staph. aureus for detection of oxacillin resistance. METHODS: A total of 106 clinical isolates of Staph. aureus were tested for oxacillin resistance by disc diffusion, screen agar plates (3 micrograms and 6 micrograms/ml of oxacillin), oxacillin broth (3 micrograms/ml) and mecA based PCR. RESULTS: PCR detected mecA gene amplified product of 604 bp in 57 strains. Disc diffusion failed to detect 7 mecA positive strains but identified 5 mecA negative strains as oxacillin resistant. Screen agar 3 micrograms, screen agar 6 micrograms and oxacillin broth 3 micrograms detected 55, 53 and 55 respectively of the 57 mecA positive strains; however, they also falsely identified 5, 3 and 3 strains of mecA negative strains respectively as oxacillin resistant. The sensitivity, specificity and accuracy of disc diffusion, 3 micrograms screen agar, 6 micrograms screen agar and 3 micrograms oxacillin broth against PCR as gold standard were as follows: 87.7, 89.9 and 88.7 per cent; 96.5, 89.8 and 93.4 per cent; 93.0, 93.9 and 93.4 per cent; 96.5, 93.9 and 95.3 per cent respectively. INTERPRETATION & CONCLUSIONS: The present study demonstrated that disc diffusion test was least reliable and 3 micrograms broth had the highest sensitivity and specificity when compared with PCR for detection of oxacillin resistance. Because of variations among the methods, a combination of tests should be used for the accurate detection of MRSA till new guidelines by an appropriate body are formulated.


Subject(s)
Base Sequence , DNA Primers , Methicillin Resistance , Polymerase Chain Reaction/methods , Staphylococcus aureus/drug effects
4.
Article in English | IMSEAR | ID: sea-22304

ABSTRACT

A total of 213 and 208 yeasts were isolated as nosocomial pathogens from various infected specimens during 1996 and 1997 respectively. Yeasts ranked fifth among uropathogens in both the years and from eighth to eleventh in other specimens. Increasing trend in nosocomial urinary tract yeast infection (11.9 in 1996 to 12.6 in 1997) and decreasing trend in wound and other infections (5.1 in 1996 to 2.9 in 1997) per 1000 patients' discharges were observed; blood stream infection remained unchanged (2/1000 discharges) in both the years. Eighty two (41 from each year) randomly selected yeasts were identified to species level following standard protocol and tested for antifungal susceptibility against fluconazole and amphotericin B by reference broth macrodilution technique and agar dilution (AD) method. The frequency of various yeast species identified was Candida albicans 39 (47.6%), C.tropicalis 29 (35.4%), C. krusei 4 (4.9%), C. glabrata 3 (3.7%), C. zeylanoides 2 (2.4%), C. guilliermondii 2 (2.4%), one strain (1.2%) each of C. kefyr, C. parapsilosis, and Trichosporon beigelii. Resistance to fluconazole (MIC > or = 64 micrograms/ml) as per NCCLS criteria was observed in 2 Candida sp. (2.4%). Significantly higher number of non-albicans Candida sp. (8/43; 18.6%) had MIC > 8 micrograms/ml as compared to C. albicans (2/39; 5.1%) (P < 0.05). Only one strain of C. tropicalis had MIC 8 micrograms/ml to amphotericin B and none had MIC > 8 micrograms/ml. Agreement between the reference and the AD methods for fluconazole was 88 per cent and for amphotericin B was 94 per cent. The present study indicates that Candida sp. are emerging as important nosocomial pathogens and the tendency of yeasts to develop resistance to antifungal agents appears to be a challenge for patient management.


Subject(s)
Amphotericin B/pharmacology , Antifungal Agents/pharmacology , Candida/classification , Cross Infection/microbiology , Fluconazole/pharmacology , Humans , Microbial Sensitivity Tests , Species Specificity , Trichosporon/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL